W J Heinz
Overview
Explore the profile of W J Heinz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1075
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cruciani M, White P, Mengoli C, Loffler J, Morton C, Klingspor L, et al.
J Antimicrob Chemother
. 2020 Dec;
76(3):635-638.
PMID: 33374010
Background: The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be...
2.
Heimann S, Vehreschild M, Cornely O, Heinz W, Gruner B, Silling G, et al.
J Hosp Infect
. 2018 Nov;
101(3):339-346.
PMID: 30423409
Background: Invasive mucormycosis (IM) is a rare invasive fungal infection with a high mortality rate. However, data concerning the clinical and economic burden of IM are scarce. Aim: To evaluate...
3.
Rieger C, Liss B, Mellinghoff S, Buchheidt D, Cornely O, Egerer G, et al.
Ann Oncol
. 2018 Apr;
29(6):1354-1365.
PMID: 29688266
Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical...
4.
Ullmann A, Aguado J, Arikan-Akdagli S, Denning D, Groll A, Lagrou K, et al.
Clin Microbiol Infect
. 2018 Mar;
24 Suppl 1:e1-e38.
PMID: 29544767
The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis....
5.
Heinz W, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely O, Einsele H, et al.
Ann Hematol
. 2017 Sep;
96(11):1775-1792.
PMID: 28856437
Fever may be the only clinical symptom at the onset of infection in neutropenic cancer patients undergoing myelosuppressive chemotherapy. A prompt and evidence-based diagnostic and therapeutic approach is mandatory. A...
6.
Boch T, Spiess B, Cornely O, Vehreschild J, Rath P, Steinmann J, et al.
Clin Microbiol Infect
. 2016 Jul;
22(10):862-868.
PMID: 27393123
High mortality rates of invasive fungal disease (IFD), especially invasive aspergillosis (IA), in immunocompromised haematological patients and current diagnostic limitations require improvement of detection of fungal pathogens by defining the...
7.
Boch T, Reinwald M, Postina P, Cornely O, Vehreschild J, Heussel C, et al.
Mycoses
. 2015 Oct;
58(12):735-45.
PMID: 26497302
The increasing incidence of invasive fungal diseases (IFD), most of all invasive aspergillosis (IA) in immunocompromised patients emphasises the need to improve the diagnostic tools for detection of fungal pathogens....
8.
Springer J, Lackner M, Nachbaur D, Girschikofsky M, Risslegger B, Mutschlechner W, et al.
Clin Microbiol Infect
. 2015 Sep;
22(1):80-86.
PMID: 26400571
Invasive aspergillosis (IA) is associated with significant morbidity and mortality, and, among other factors, this is due to a delay in diagnosis performed with conventional techniques. A prospective, multicentre study...
9.
Wiebecke S, Schulze P, Heinz W, Klinker H
Dtsch Med Wochenschr
. 2014 May;
139(23):1216-9.
PMID: 24866953
No abstract available.
10.
Nucci M, Marr K, Vehreschild M, De Souza C, Velasco E, Cappellano P, et al.
Clin Microbiol Infect
. 2013 Oct;
20(6):580-5.
PMID: 24118322
Invasive fusariosis (IF) has been associated with a poor prognosis. Although recent series have reported improved outcomes, the definition of optimal treatments remains controversial. The objective of this study was...